Evaluation of efficacy and safety of esmolol in treating patients with septic shock by Bin Hou, MM, Ke Cai, MM, Yue Li, MM, Chunfang Hu, MM, Xuehua Pu, MD

Get full text

Triglyceride-glucose Index as a Valuable Marker to Predict Severity of Coronary Artery Disease: A Retrospective Cohort Study by Xu Geng MM, Xi Zhang PhD, XiaoWei Li MM, ChunTing Zhong MM, Min Hou MM

Get full text

The Use of Machine Learning Techniques to Predict Deep Vein Thrombosis in Rehabilitation Inpatients by Tingting Hou MM, Wei Qiao MM, Sijin Song MM, Yingchao Guan MM, Chunyang Zhu MS, Qing Yang MM, Qi Gu MM, Li Sun MM, Su Liu MD

Get full text

Risk Factors of Thromboembolism in Lymphoma Patients Undergoing Chemotherapy and its Clinical Significance by Xiao Li MM, Shu-Ling Hou MM, Xi Li MM, Li Li MM, Ke Lian MM, Ju-Ya Cui MM, Gang-Gang Wang MM, Tao Yang PhD

Get full text

Transarterial Chemoembolization Combined With PD-1 Inhibitors Plus Lenvatinib Showed Improved Efficacy for Treatment of Unresectable Hepatocellular Carcinoma Compared With PD-1 Inh... by Jinfeng Wang MM, Man Zhao MM, Guangjie Han MM, Xin Han MM, Jianfei Shi PhD, Lili Mi PhD, Ning Li BM, Xiaolei Yin MM, Xiaoling Duan PhD, Jiaojiao Hou MM, Fei Yin PhD

Get full text

PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial by Martinez, FJ, White, M, Guillotte-Blisnick, M, Huon, C, Boucharlat, A, Agou, F, England, P, Popovici, J, Hou, MM, Silk, SE, Barrett, JR, Nielsen, CM, Reimer, JM, Mukherjee, P, Chauhan, VS, Minassian, AM, Draper, SJ, Chitnis, CE

Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: safety and parasite growth dynamics by Salkeld, J, Themistocleous, Y, Barrett, JR, Mitton, CH, Rawlinson, TA, Payne, RO, Hou, MM, Khozoee, B, Edwards, NJ, Nielsen, CM, Sandoval, DM, Bach, FA, Nahrendorf, W, Ramon, RL, Baker, M, Ramos-Lopez, F, Folegatti, PM, Quinkert, D, Ellis, KJ, Poulton, ID, Lawrie, AM, Cho, J-S, Nugent, FL, Spence, PJ, Silk, SE, Draper, SJ, Minassian, AM

Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial by Silk, SE, Kalinga, WF, Salkeld, J, Mtaka, IM, Ahmed, S, Milando, F, Diouf, A, Bundi, CK, Balige, N, Hassan, O, Mkindi, CG, Rwezaula, S, Athumani, T, Mswata, S, Lilolime, NS, Simon, B, Msami, H, Mohamed, M, David, DM, Mohammed, L, Nyaulingo, G, Mwalimu, B, Juma, O, Mwamlima, TG, Sasamalo, IA, Mkumbange, RP, Kamage, JJ, Barrett, JR, King, LDW, Hou, MM, Pulido, D, Carnrot, C, Lawrie, AM, Cowan, RE, Nugent, FL, Roberts, R, Cho, J-S, Long, CA, Nielsen, CM, Miura, K, Draper, SJ, Olotu, AI, Minassian, AM

Controlled human malaria infection with a clone of Plasmodium vivax with high quality genome assembly by Minassian, AM, Themistocleous, Y, Silk, SE, Barrett, JR, Kemp, A, Quinkert, D, Nielsen, CM, Edwards, NJ, Rawlinson, TA, Ramos Lopez, F, Roobsoong, W, Ellis, KJ, Cho, J-S, Aunin, E, Otto, TD, Reid, AJ, Bach, FA, Labbé, GM, Poulton, ID, Marini, A, Zaric, M, Mulatier, M, Lopez Ramon, R, Baker, M, Mitton, CH, Sousa, JC, Rachaphaew, N, Kumpitak, C, Maneechai, N, Suansomjit, C, Piteekan, T, Hou, MM, Khozoee, B, McHugh, K, Roberts, DJ, Lawrie, AM, Blagborough, AM, Nugent, FL, Taylor, IJ, Johnson, KJ, Spence, PJ, Sattabongkot, J, Biswas, S, Rayner, JC, Draper, SJ

Leritrelvir for the treatment of mild or moderate COVID-19 without co-administered ritonavir: a multicentre randomised, double-blind, placebo-controlled phase 3 trialResearch in co... by Yangqing Zhan, Zhengshi Lin, Jingyi Liang, Ruilin Sun, Yueping Li, Bingliang Lin, Fangqi Ge, Ling Lin, Hongzhou Lu, Liang Su, Tianxin Xiang, Hongqiu Pan, Chaolin Huang, Ying Deng, Furong Wang, Ruhong Xu, Dexiong Chen, Ping Zhang, Jianlin Tong, Xifu Wang, Qingwei Meng, Zhigang Zheng, Shuqiang Ou, Xiaoyun Guo, Herui Yao, Tao Yu, Weiyang Li, Yu Zhang, Mei Jiang, Zhonghao Fang, Yudi Song, Ruifeng Chen, Jincan Luo, Changyuan Kang, Shiwei Liang, Haijun Li, Jingping Zheng, Nanshan Zhong, Zifeng Yang, Huang Yanming, M.M, Dong Haiping, M.D., Jinlin Hou, M.M, Shao Lei, M.D., Li Xiaoguang, M.D., Gao Yan, M.M.

Get full text

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial by Ramasamy, MN, Minassian, AM, Ewer, KJ, Flaxman, AL, Folegatti, PM, Owens, DR, Voysey, M, Aley, PK, Angus, B, Babbage, G, Belij-Rammerstorfer, S, Berry, L, Bibi, S, Bittaye, M, Cathie, K, Chappell, H, Charlton, S, Cicconi, P, Clutterbuck, EA, Colin-Jones, R, Dold, C, Emary, KRW, Fedosyuk, S, Fuskova, M, Gbesemete, D, Green, C, Hallis, B, Hou, MM, Jenkin, D, Joe, CCD, Kelly, EJ, Kerridge, S, Lawrie, AM, Lelliott, A, Lwin, MN, Makinson, R, Marchevsky, NG, Mujadidi, Y, Munro, APS, Pacurar, M, Plested, E, Rand, J, Rawlinson, T, Rhead, S, Robinson, H, Ritchie, AJ, Ross-Russell, AL, Saich, S, Singh, N, Pollard, AJ, Oxford COVID Vaccine Trial Group